
Immunic, Inc.
IMUX·NASDAQ
Last updated as of 2026-07-09 10:07 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
IMUX stock price change
On the last trading day, IMUX stock closed at 8.80 USD, with a price change of -4.16% for the day.
Trade spot stocks (24/7)Bitget's stock quote pages provide comprehensive information on IMUX stock, including real-time prices, historical price charts, key data, price performance analysis, daily briefings, analyst forecasts, the latest news, business overviews, and financial analysis—all in one place. You can access real-time stock price information for Immunic, Inc. (IMUX), including 24-hour price movements, historical price charts, 52-week high and low ranges, market capitalization, trading volume, and key financial metrics such as price-to-earnings ratio, quarterly revenue, and earnings per share. You can also stay up to date on Immunic, Inc.'s stock price outlook and latest developments through analyst consensus price targets and curated news coverage. Information sources include NASDAQ stock exchange data, TradingView data, Immunic, Inc. financial reports, analysis from leading Wall Street institutions and analysts, and articles from major financial media outlets.
IMUX key data
Previous close8.80 USD
Market cap119.88M USD
Volume389.35K
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-0.75 USD
Net income (FY)−97.17M USD
Revenue (FY)0.00 USD
Next report dateAug 6, 2026
EPS estimate-
Revenue estimate-
Shares float13.49M
Beta (1Y)0.43

Bitget ushers in the Stocks 2.0 era:
A new way to trade stocks — anytime, anywhere, 24/7.
Access Wall Street liquidity, dividend payouts, and futures margin support.
Learn moreImmunic, Inc. overview
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
Erik Lundgren
Headquarters
New York
Website
imux.com
Founded
2003
Employees (FY)
92
Change (1Y)
+1 +1.10%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
−1.06M USD
IMUX stock price forecast
According to technical indicators for IMUX stock, the price is likely to fluctuate within the range of 10.36–10.72 USD over the next week. Market analysts predict that the price of IMUX stock will likely fluctuate within the range of 8.28–12.37 USD over the next months.
Based on 1-year price forecasts from 43 analysts, the highest estimate is 17.84 USD, while the lowest estimate is 7.68 USD.
For more information, please see the
IMUX stock price forecast
page.
Trending stocks
Trade spot stocks on Bitget
Trade stock perps on Bitget
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn moreLatest IMUX stock news
The latest round of funding raised by Immunic, Inc. is expected to strongly support the company's strategic transformation—from a biotechnology enterprise focused on research and development to a fully integrated commercial entity with a complete industry chain.
老虎证券2026-02-13 11:56:56
Biopharmaceutical company Immunic, Inc. announced that its co-founder and current CEO, Daniel Vitt, will work with the board of directors to initiate the search for a new CEO.
老虎证券2026-02-13 11:57:57
Immunic Stock Jumps After Pricing $400 Million Private Placement
Finviz2026-02-13 16:27:42
Why Is Immunic Stock Soaring Friday?
Finviz2026-02-13 18:57:12
Biopharmaceutical company Immunic, Inc. recently announced the appointment of experienced industry executive Jon Congleton to its board of directors.
老虎证券2026-03-31 10:41:01
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), the biopharmaceutical company Immunic, Inc. has initiated an equity resale program.
老虎证券2026-04-02 20:53:03
Biopharmaceutical company Immunic, Inc. has officially announced the appointment of Dr. Michael A. Panzara, M.D., M.P.H., who has extensive experience in the biopharmaceutical field, as Chief Medical Officer.
老虎证券2026-04-28 10:38:04
The latest round of funding raised by Immunic, Inc. is expected to strongly support the company's strategic transformation—from a biotechnology enterprise focused on research and development to a fully integrated commercial entity with a complete industry chain.
老虎证券2026-02-13 11:56:56
Biopharmaceutical company Immunic, Inc. announced that its co-founder and current CEO, Daniel Vitt, will work with the board of directors to initiate the search for a new CEO.
老虎证券2026-02-13 11:57:57
Immunic Stock Jumps After Pricing $400 Million Private Placement
Finviz2026-02-13 16:27:42
Why Is Immunic Stock Soaring Friday?
Finviz2026-02-13 18:57:12
Biopharmaceutical company Immunic, Inc. recently announced the appointment of experienced industry executive Jon Congleton to its board of directors.
老虎证券2026-03-31 10:41:01
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), the biopharmaceutical company Immunic, Inc. has initiated an equity resale program.
老虎证券2026-04-02 20:53:03
